Stacy W. Gray, MD, AM
Stacy W. Gray, M.D., A.M., is professor and chief of the Division of Clinical Cancer Genomics within the Department of Medical Oncology & Therapeutics Research and a secondary appointment in the Department of Population Sciences.
Dr. Gray earned her undergraduate degree from Brown University. She received both her master’s degree in public policy and her medical doctorate from University of Chicago. She completed her internal medicine residency and hematology/oncology fellowship at University of Chicago Hospitals.
During her clinical training, she was awarded an Irving B. Harris Fellowship. Subsequently, she completed a research fellowship at the National Cancer Institute-funded Center of Excellence in Cancer Communication Research at University of Pennsylvania’s Annenberg School for Communication.
She continued her research training through a second postdoctoral fellowship at Massachusetts General Hospital, simultaneously joining Dana-Farber as a medical oncologist and cancer outcomes researcher in the Division of Population Sciences and the Lowe Center for Thoracic Oncology.
Dr. Gray's research is in translational genomics. She is working to understand the factors that drive the use of novel and established cancer genomic tests and therapies, identify gaps in lung cancer prevention, research and care, and design interventions to improve the delivery of precision cancer medicine.
Dr. Gray served on the ASCO Cancer Research Committee, holds multiple leadership roles in an National Institutes of Health research consortium, and has presented her research both nationally and internationally. She has numerous peer-reviewed publications in such journals as Journal of Clinical Oncology, Journal of the National Cancer Institute, Journal of Oncology Practice, and Genetics in Medicine.
Dr. Gray also has a strong track record of research funding and has been supported by National Human Genome Research Institute, Agency for Healthcare Research and Quality, American Cancer Society, American Society of Clinical Oncology and Robert Wood Johnson Foundation.
Built by One Eleven